| Name | Title | Contact Details |
|---|---|---|
Amy Stafford |
VP of Sales | Profile |
Melissa Wolfe Beiner |
Director of Research and Development | Profile |
Gene Dubowchik |
VP Chemistry, Research and Development | Profile |
Loren Aguiar |
VP, Research And Development | Profile |
Matt Buten |
Chief Financial Officer | Profile |
The Cerulean team is committed to improving treatment for people living with cancer. We apply our Dynamic Tumor Targeting Platform to create a portfolio of NDCs designed to selectively attack tumor cells, reduce toxicity by sparing the body’s normal cells, and enable therapeutic combinations. Our first platform-generated candidate, CRLX101, is in multiple clinical trials in combination with other cancer treatments, all of which aim to unlock the power of combination therapy. Our second platform-generated candidate, CRLX301, is in a Phase 1/2a clinical trial.
Hepion Pharmaceuticals is a biopharmaceutical company focused on the development of pleiotropic drug therapy for treatment of chronic liver disease. T
Pharm Agra Labs is a Brevard, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Covx Pharmaceuticals is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Agensys is a Santa Monica, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.